Literature DB >> 2783681

T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.

T Boon1, A Van Pel.   

Abstract

It is now widely accepted that cytolytic T cells recognize their antigens in the form of small peptides bound to major histocompatibility complex molecules at the surface of the target cells. We present here the hypothesis that, when these antigenic peptides are derived from the cellular genome, they are not degradation products of cellular proteins but can be generated directly by the autonomous transcription and translation of short subgenic regions that we propose to name "peptons". We discuss some consequences of the notion that antigenic peptides can be produced in the absence of synthesis of messenger RNA and protein from the corresponding genes.

Mesh:

Substances:

Year:  1989        PMID: 2783681     DOI: 10.1007/BF00395854

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  27 in total

1.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein.

Authors:  A R Townsend; F M Gotch; J Davey
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

2.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

3.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

4.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

5.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

6.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

7.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.

Authors:  C Uyttenhove; J Van Snick; T Boon
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

8.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.

Authors:  J L Maryanski; J Van Snick; J C Cerottini; T Boon
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

9.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

10.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  34 in total

1.  Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond.

Authors:  Heather D Hickman; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

2.  The pepton hypothesis and autoimmunity.

Authors:  I R Mackay; M Rowley; B Loveland; S Marzuki
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Do we need a pepton hypothesis?

Authors:  K F Lindahl
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen.

Authors:  D E Speiser; T Zürcher; H Ramseier; H Hengartner; P Staeheli; O Haller; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Variable spread of X inactivation affecting the expression of different epitopes of the Hya gene product in mouse B-cell clones.

Authors:  D Scott; A McLaren; J Dyson; E Simpson
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  The genetic origin of minor histocompatibility antigens.

Authors:  D C Roopenian; G J Christianson; A P Davis; A R Zuberi; L E Mobraaten
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 7.  Antigen processing by proteasomes: insights into the molecular basis of crypticity.

Authors:  H Djaballah
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

8.  Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.

Authors:  Brian P Dolan; Lily Li; Charles A Veltri; Chris M Ireland; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

9.  Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.

Authors:  Diego J Farfán-Arribas; Lawrence J Stern; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

10.  Efficient expression of tum- antigen P91A by transfected subgenic fragments.

Authors:  P Chomez; E De Plaen; A Van Pel; C De Smet; J P Szikora; C Lurquin; A M Lebacq-Verheyden; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.